The $26 billion drug just went generic: Semaglutide's patent expiry On March 20, Novo Nordisk lost its compound patent on semaglutide in India.....and the generic flood began within hours
Trimi's published homepage displays a figure of 53,585+ patients, which should be treated as brand-stated information - it hasn't been independently audited by this publication
NETs can trap and kill pathogens but also cause local obstruction in the lungs, promoting mucin overproduction and furthering inflammation and thrombosis, contributing to severe lung injury and poor outcomes in COVID-19 patients (125127)
Most guidelines suggest using reconstituted peptide solutions within 28 to 30 days, even if the original powder had a longer shelf life
Among patients with biopsy-confirmed MASLD and F2-F3 fibrosis, 80% already met eligibility criteria for semaglutide through existing indications
This is especially important for people with diabetes, as they often have reduced kidney function